About Eliem Therapeutics, Inc. 
Eliem Therapeutics, Inc.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available
Shareholding Snapshot
Shareholding Compare (%holding) 
Majority shareholders
Strategic Entities
Domestic Funds
Held in 17 Schemes (11.21%)
Foreign Institutions
Held by 36 Foreign Institutions (6.88%)
Strategic Entities with highest holding
Highest Public shareholder
Management
Designation
No Data
Revenue and Profits:
Net Sales:
(Quarterly Results - Mar 2026)
Net Profit:
-14 Million
Pharmaceuticals & Biotechnology
USD 335 Million (Micro Cap)
NA (Loss Making)
NA
0.00%
-0.63
-37.30%
2.09






